Zinman, Bernard
,
Inzucchi, Silvio E.
Wanner, Christoph
Hehnke, Uwe
George, Jyothis T.
Johansen, Odd Erik
Fitchett, David
Funding for this research was provided by:
Boehringer Ingelheim
Eli Lilly and Company
Article History
Received: 28 October 2017
Accepted: 4 April 2018
First Online: 30 April 2018
Duality of interest
: BZ has received research grants awarded to his institution from Boehringer Ingelheim, AstraZeneca and NovoNordisk (significant), honoraria from Janssen, Sanofi and Eli Lilly and Company (modest), and honoraria from Boehringer Ingelheim, NovoNordisk and Merck (significant). SEI reports honoraria from AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eisai, Janssen, Intarcia Therapeutics, Inc., Novo Nordisk, Sanofi/Lexicon, vTv Therepeutics (modest). CW reports honoraria from Bayer, Boehringer Ingelheim, Janssen and Sanofi. UH, JTG and OEJ are employed by Boehringer Ingelheim. DF reports honoraria from Sanofi, Merck & Co., Amgen, AstraZeneca, Eli Lilly and Company (modest) and Boehringer Ingelheim (significant).